UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060944
Receipt number R000069744
Scientific Title A retrospective observational study evaluating the association between initial treatment and clinical course in patients with zoster-associated pain
Date of disclosure of the study information 2026/03/18
Last modified on 2026/03/16 14:38:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Initial treatment and clinical course of zoster-associated pain: a retrospective study

Acronym

Zoster-associated pain initial treatment study

Scientific Title

A retrospective observational study evaluating the association between initial treatment and clinical course in patients with zoster-associated pain

Scientific Title:Acronym

ZAP-IT study

Region

Japan


Condition

Condition

Zoster associated pain

Classification by specialty

Medicine in general Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study retrospectively investigates the pain course of patients who received oral medication treatment in our department, particularly those who were not properly prescribed oral medication.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

NRS decrease or improvement in pain

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

39 years-old <=

Age-upper limit

88 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients referred for shingles-related pain between January 1, 2020 and December 31, 2025

Key exclusion criteria

More than 12 weeks have passed since the referral.
The patient is regularly prescribed NSAIDs, acetaminophen, and tramadol.

Target sample size

115


Research contact person

Name of lead principal investigator

1st name Kazumi
Middle name
Last name Nakamatsu

Organization

Wakayama Medical University Hospital

Division name

Department of Anesthesiology

Zip code

6418509

Address

Wakayama ken Wakayama-shi Kimiidera 811 - 1 17 811-1 Kimidera, Wakayama City, Wakayama Prefecture

TEL

0734472300

Email

knakamatsu@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Kazumi
Middle name
Last name Nakamatsu

Organization

Wakayama Medical University Hospital

Division name

Department of Anesthesiology

Zip code

641-8509

Address

Wakayama ken Wakayama-shi Kimiidera 811 - 1 17 811-1 Kimidera, Wakayama City, Wakayama Prefecture

TEL

073-441-0611

Homepage URL


Email

www-admin@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Wakayama Medical University

Address

811-1 Kimidera, Wakayama City, Wakayama Prefecture

Tel

0734472300

Email

www-admin@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

115

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2026 Year 01 Month 31 Day

Date of IRB

2026 Year 03 Month 31 Day

Anticipated trial start date

2026 Year 02 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study included patients referred for shingles-related pain between January 1, 2020, and December 31, 2025.


Management information

Registered date

2026 Year 03 Month 16 Day

Last modified on

2026 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069744